A phase three clinical trial determined that a 3-drug combination improved lung function and reduced symptoms in cystic fibrosis (CF) patients who have a single copy of the most common genetic ...
Hosted on MSN
Vertex and Ono Pharmaceutical form exclusive alliance for Povetacicept in Japan and South Korea
Vertex Pharmaceuticals (Nasdaq: NASDAQ:VRTX) and Ono Pharmaceutical (OTCMKTS: OTCPK:OPHLY) have announced an exclusive collaboration, for the development and commercialization of Vertex's povetacicept ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback